This scholarly profile was discovered from public research metadata and has not yet been claimed. Is this your research profile?
Hugo Ten Cate
UnverifiedResearcher · NL
Publications
10
Citations
8635
max across sources
Profile views
1
bot-filtered
Verification
L0
Overview
AI-generatedHugo Ten Cate (RTX-00000211) based in NL is a researcher on ResearchTrics. Lists research interests: atrial fibrillation management and outcomes, blood coagulation and thrombosis mechanisms, coagulation, bradykinin, polyphosphates, and angioedema, metabolism and genetic disorders, venous thromboembolism diagnosis and management. Has 10 publications recorded, including "2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)" (2024), "Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands" (2020), "Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians" (2017).
An AI overview generated from this profile’s verified records — an interpretation, not a verified statement.
Research interests
- atrial fibrillation management and outcomes
- blood coagulation and thrombosis mechanisms
- coagulation, bradykinin, polyphosphates, and angioedema
- metabolism and genetic disorders
- venous thromboembolism diagnosis and management
Publications (17)
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2930 cites
European Heart Journal · 2024 · DOI
- Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians383 cites
Journal of Thrombosis and Haemostasis · 2017 · DOI
- Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State449 cites
Arteriosclerosis Thrombosis and Vascular Biology · 2013 · DOI
- The Hemostatic System as a Modulator of Atherosclerosis570 cites
New England Journal of Medicine · 2011 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Thalassemia Syndromes475 cites
journal article · 2009 · DOI
- Disseminated Intravascular Coagulation2004 cites
New England Journal of Medicine · 1999 · DOI
- Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.386 cites
The Journal of Experimental Medicine · 1994 · DOI
- Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.410 cites
Journal of Clinical Investigation · 1994 · DOI
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects671 cites
New England Journal of Medicine · 1990 · DOI
